Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Barchiesi

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
The Journal of Antimicrobial Chemotherapy|October 6, 2000
Inhibition of growth of Pneumocystis carinii by lactoferrins alone and in combination with pyrimethamine, clarithromycin and minocyclineO Cirioni, A Giacometti, F Barchiesi, et al.
The Journal of Antimicrobial Chemotherapy|November 18, 1998
In-vitro activity of lytic peptides alone and in combination with macrolides and inhibitors of dihydrofolate reductase against Pneumocystis cariniiO Cirioni, A Giacometti, F Barchiesi, et al.
Journal of Chemotherapy (Florence, Italy)|June 1, 1991
Fluconazole, itraconazole and ketoconazole in-vitro activity. A comparative studyD Arzeni, F Barchiesi, F Ancarani, et al.
The Journal of Antimicrobial Chemotherapy|March 7, 2000
Anticryptosporidial activity of ranalexin, lasalocid and azithromycin alone and in combination in cell linesA Giacometti, O Cirioni, F Barchiesi, et al.
The Journal of Antimicrobial Chemotherapy|September 17, 1998
In-vitro activity of lytic peptides, inhibitors of ion transport systems and ionophorous antibiotics against Pneumocystis cariniiO Cirioni, A Giacometti, F Barchiesi, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1997
In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azolesF Barchiesi, L Falconi Di Francesco, G Scalise
Diagnostic Microbiology and Infectious Disease|October 18, 2000
In-vitro activity and killing effect of polycationic peptides on methicillin-resistant Staphylococcus aureus and interactions with clinically used antibioticsA Giacometti, O Cirioni, F Barchiesi, et al.
Mycopathologia|September 17, 2011
Heterozygosis and pathogenicity of Cryptococcus neoformans AD-hybrid isolatesM Cogliati, F Barchiesi, E Spreghini, et al.
The Journal of Antimicrobial Chemotherapy|May 8, 2000
In vitro anti-cryptosporidial activity of cationic peptides alone and in combination with inhibitors of ion transport systemsA Giacometti, O Cirioni, F Barchiesi, et al.
The Journal of Antimicrobial Chemotherapy|December 20, 1999
In-vitro activity of rifabutin and albendazole singly and in combination with other clinically used antimicrobial agents against Pneumocystis cariniiO Cirioni, A Giacometti, F Barchiesi, et al.
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
The Journal of Antimicrobial Chemotherapy|October 6, 2000
Inhibition of growth of Pneumocystis carinii by lactoferrins alone and in combination with pyrimethamine, clarithromycin and minocyclineO Cirioni, A Giacometti, F Barchiesi, et al.
The Journal of Antimicrobial Chemotherapy|November 18, 1998
In-vitro activity of lytic peptides alone and in combination with macrolides and inhibitors of dihydrofolate reductase against Pneumocystis cariniiO Cirioni, A Giacometti, F Barchiesi, et al.
Journal of Chemotherapy (Florence, Italy)|June 1, 1991
Fluconazole, itraconazole and ketoconazole in-vitro activity. A comparative studyD Arzeni, F Barchiesi, F Ancarani, et al.
The Journal of Antimicrobial Chemotherapy|March 7, 2000
Anticryptosporidial activity of ranalexin, lasalocid and azithromycin alone and in combination in cell linesA Giacometti, O Cirioni, F Barchiesi, et al.
The Journal of Antimicrobial Chemotherapy|September 17, 1998
In-vitro activity of lytic peptides, inhibitors of ion transport systems and ionophorous antibiotics against Pneumocystis cariniiO Cirioni, A Giacometti, F Barchiesi, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1997
In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azolesF Barchiesi, L Falconi Di Francesco, G Scalise
Diagnostic Microbiology and Infectious Disease|October 18, 2000
In-vitro activity and killing effect of polycationic peptides on methicillin-resistant Staphylococcus aureus and interactions with clinically used antibioticsA Giacometti, O Cirioni, F Barchiesi, et al.
Mycopathologia|September 17, 2011
Heterozygosis and pathogenicity of Cryptococcus neoformans AD-hybrid isolatesM Cogliati, F Barchiesi, E Spreghini, et al.
The Journal of Antimicrobial Chemotherapy|May 8, 2000
In vitro anti-cryptosporidial activity of cationic peptides alone and in combination with inhibitors of ion transport systemsA Giacometti, O Cirioni, F Barchiesi, et al.
The Journal of Antimicrobial Chemotherapy|December 20, 1999
In-vitro activity of rifabutin and albendazole singly and in combination with other clinically used antimicrobial agents against Pneumocystis cariniiO Cirioni, A Giacometti, F Barchiesi, et al.
Pageof 9